Royce & Associates’s Apyx Medical APYX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.64M | Buy |
2,611,224
+168,189
| +7% | +$629K | 0.1% | 339 |
|
|
2025
Q4 | $8.55M | Sell |
2,443,035
-31,364
| -1% | -$109K | 0.09% | 355 |
|
|
2025
Q3 | $5.3M | Buy |
2,474,399
+34,696
| +1% | +$73.4K | 0.05% | 460 |
|
|
2025
Q2 | $5.49M | Sell |
2,439,703
-85,764
| -3% | -$121K | 0.06% | 437 |
|
|
2025
Q1 | $3.46M | Sell |
2,525,467
-89,902
| -3% | -$124K | 0.04% | 502 |
|
|
2024
Q4 | $4.13M | Buy |
2,615,369
+32,879
| +1% | +$46K | 0.04% | 523 |
|
|
2024
Q3 | $3.2M | Buy |
2,582,490
+85,267
| +3% | +$108K | 0.03% | 556 |
|
|
2024
Q2 | $3.35M | Buy |
2,497,223
+60,564
| +2% | +$89.3K | 0.03% | 548 |
|
|
2024
Q1 | $3.31M | Buy |
2,436,659
+277,759
| +13% | +$591K | 0.03% | 561 |
|
|
2023
Q4 | $5.66M | Buy |
2,158,900
+149,300
| +7% | +$361K | 0.05% | 469 |
|
|
2023
Q3 | $6.43M | Buy |
2,009,600
+406,624
| +25% | +$1.89M | 0.07% | 415 |
|
|
2023
Q2 | $8.06M | Buy |
1,602,976
+145,759
| +10% | +$738K | 0.08% | 366 |
|
|
2023
Q1 | $4.2M | Buy |
1,457,217
+658,749
| +83% | +$1.92M | 0.04% | 521 |
|
|
2022
Q4 | $1.87M | Sell |
798,468
-85,800
| -10% | -$262K | 0.02% | 657 |
|
|
2022
Q3 | $3.97M | Buy |
884,268
+415,000
| +88% | +$2.97M | 0.04% | 494 |
|
|
2022
Q2 | $2.75M | Buy |
469,268
+6,800
| +1% | +$34.9K | 0.03% | 615 |
|
|
2022
Q1 | $3.02M | Sell |
462,468
-11,600
| -2% | -$114K | 0.03% | 651 |
|
|
2021
Q4 | $6.08M | Sell |
474,068
-69,732
| -13% | -$975K | 0.05% | 517 |
|
|
2021
Q3 | $7.53M | Sell |
543,800
-15,000
| -3% | -$158K | 0.06% | 489 |
|
|
2021
Q2 | $5.76M | Hold |
558,800
| – | – | 0.04% | 576 |
|
|
2021
Q1 | $5.4M | Hold |
558,800
| – | – | 0.04% | 584 |
|
|
2020
Q4 | $4.02M | Hold |
558,800
| – | – | 0.03% | 593 |
|
|
2020
Q3 | $2.63M | Buy |
558,800
+204,900
| +58% | +$1.01M | 0.03% | 630 |
|
|
2020
Q2 | $1.96M | Sell |
353,900
-37,131
| -9% | -$154K | 0.02% | 669 |
|
|
2020
Q1 | $1.4M | Sell |
391,031
-120,784
| -24% | -$811K | 0.02% | 677 |
|
|
2019
Q4 | $4.33M | Buy |
511,815
+45,900
| +10% | +$332K | 0.04% | 523 |
|
|
2019
Q3 | $3.15M | Buy |
465,915
+113,400
| +32% | +$805K | 0.03% | 599 |
|
|
2019
Q2 | $2.37M | Sell |
352,515
-402,900
| -53% | -$2.19M | 0.02% | 686 |
|
|
2019
Q1 | $4.77M | Buy |
755,415
+60,415
| +9% | +$467K | 0.04% | 514 |
|
|
2018
Q4 | $4.5M | Sell |
695,000
-15,000
| -2% | -$90.9K | 0.04% | 528 |
|
|
2018
Q3 | $5.04M | Hold |
710,000
| – | – | 0.03% | 597 |
|
|
2018
Q2 | $3.09M | Buy |
710,000
+23,400
| +3% | +$86.3K | 0.02% | 731 |
|
|
2018
Q1 | $2.04M | Buy |
686,600
+28,600
| +4% | +$73.6K | 0.01% | 848 |
|
|
2017
Q4 | $1.71M | Buy |
+658,000
| New | +$2.05M | 0.01% | 873 |
|
Other funds holding APYX
NCM
ACM
VCM
ACM
SBCM
EIM
HKAM
